
|Articles|May 1, 2004
Botox has long duration of action for Tx of axillary hyperhidrosis
Washington - Intradermal botulinum toxin type A (Botox) for the treatment of primary axillary hyperhidrosis produces a durable effect, with nearly half of patients requiring only one treatment over a one-year period, according to study data released at the annual meeting of the American Academy of Dermatology here.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
3
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
4
Clinicians See Intersection of Weight Loss and Facial Aging
5


















